Single Cell Analysis Market Types, Applications, Industry Trends, Drivers, Restraints, Expansion Plans & Forecast

Single-cell analysis alludes to the investigation of individual cells isolated from tissues in multi-cell living beings. Single cell analysis is a natural step in the reductionist way to study living organisms. By concentrating on each cell at a time, the outcomes are sure to originate from that specific cell. A cell can for instance be observed as it relocates or isolates into two cells, the number of divisions that happen over the long haul and the rate of cell division in a specific cell clone. Cell divisions are fascinating, for instance, the uncontrolled pace of cell multiplication of a cancer cell has different results in comparison to the multiplication of an ordinary cell.

Market overview

The Global Single Cell Analysis Market is projected to grow to a value of more than $ 8.60 billion by 2030, with a growing CAGR of over 15%.

One of the main application areas of single-cell analysis is cancer genomics. As per GLOBOCAN, the quantity of cancer cases will ascend to around 30 million by 2040 from 19.3 million cases and 10 million cancer death in 2020. The development in the pervasiveness of this illness has brought about a need to conduct extensive examination for finding a reliable treatment; single-cell analysis shapes a significant piece of this exploration. The investigation of individual cells empowers the right finding of disease and checking of treatment viability. Single-cell analysis supports the count of partner T-cells, determination of DNA content, and checking the expansion of tumour cells in breast cancer and further malignancies.

The expense of examination in single-cell biology is high because of the need to keep up with the standard (the utilization of high-grade, costly items) and conform to the rules set by administrative specialists. However, research and academic labs often find it hard to bear the cost of such expensive instruments because of budget constraint. In addition, the maintenance costs and a few other backhanded costs bring about a general expansion in the total expense of ownership of these instruments. This is the main consideration restricting the adoption of flow cytometers and microfluidic gadgets in both clinical and research applications.

Request a Free Sample Copy

Economic growth

The Global Single Cell Analysis Market size was $3.1 billion in 2021, and is projected to grow to a value of more than $8.60 billion by 2030, with a growing CAGR (compound annual growth rate) of over 15% from 2022 to 2030.

Market segmentation: Analysis

Based on product type

• Consumable

o Microplates

o Beads

o Reagents

o assay kits (Immunoassays and cell based assays)

o Other Consumables

• Instrument

o flow cytometers

o NGS Systems

o PCR Instruments

o Spectrophotometers

o Microscopes

o cell counters

o HCS systems

o Microarrays

o Others

Based on Cell type

• Human cells

• Animal Cells

• Microbial Cells

Based on workflow

• Single cell isolation & library preparation

• Downstream analysis

• Data analysis

Based on Technique

• Flow Cytometry

• Next-generation sequencing

• Polymerase Chain Reaction

• Microscopy

• Mass Spectrometry

• Others

Based on Application

• Research Application

o Cancer

o Immunology

o Neurology

o stem cell

o Others

• Medical Applications

o Non-invasive prenatal diagnosis

o In Vitro Fertilization

o circulating tumor cell detection

Based on End-User

• Academic & Research Laboratories

• Biotechnology & Pharmaceutical Companies

• Hospitals & Diagnostic Laboratories

• Cell Banks & IVF Centers

On the basis of region – North America, Europe, Asia-pacific, Latin America, and MEA.

Considering the geographic ambit, North America represented the biggest share of more than 40% of the worldwide single-cell analysis market in 2020.

Key players in the Global Single Cell Analysis Market are:

  • Thermo Fisher Scientific Inc.
  • QIAGEN NV
  • Bio-Rad Laboratories Inc.
  • Illumina Inc.
  • Merck Millipore
  • Becton, Dickinson and Company
  • Fluidigm Corporation
  • 10x Genomics, Inc.
  • BGI Group

Purchase this Report

About We Market Research

We Market Research is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.

Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. We Market Research is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.